Consistently, PTEN siRNA also abolished the discrepancy of metastasis between miR-552 overexpression ovarian cancer cells and their control cells (Fig. 6h), suggesting that miR-552 promoted ovarian cancer cell progression by directly target PTEN pathway. This evidence concerns the gene PTEN and ovarian carcinoma.